$Capricor Therapeutics (CAPR.US)$Safety: Deramiocel (CAP-1002) for Duchenne Muscular Dystrophy (DMD). They have done over 700 infusions without any significant side effects. They will continue to do these at infusion centers just to be extra safe so treatment is available if there ever was a bad reaction. Big things happening CAPR will be over 20+ soon Apextradez where winning happens XHLD alerted at .64c - think about that do you like HUGE profifs then...
$Capricor Therapeutics (CAPR.US)$ Capricor Therapeutics Announces FDA Acceptance and Priority Review of Its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy GlobeNewswire· 22 mins ago11mins Capricor Therapeutics(CAPR.US) --FDA assigns PDUFA target action date of August 31, 2025-- --If approved, deramiocel would be first therapy to treat Duchenne muscular dystrophy cardiomyopathy-- --At this time, FDA has not identified any potential review issues with the BLA-...
$Capricor Therapeutics (CAPR.US)$Reuters· just Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
1
2
Report
Green7plus
:
Please advise when it expects to FDA decision?
$Capricor Therapeutics (CAPR.US)$this thing wild af lol.. shorts want 8 and 6, Bulls want 22.50.. keep an eye on her, can shoot to 30 with no notice or tank to 6
2
2
Report
TechSavy
:
why the huge dip and then huge buyback, makes no sense
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Capricor Therapeutics Stock Forum
Capricor's DMD Breakthrough: FDA Fast-Tracks Novel Therapy as Cash Position Hits $151.5M
They have done over 700 infusions without any significant side effects. They will continue to do these at infusion centers just to be extra safe so treatment is available if there ever was a bad reaction.
Big things happening CAPR will be over 20+ soon
Apextradez where winning happens
XHLD alerted at .64c - think about that do you like HUGE profifs then...
Breakthrough: New DMD Drug Cuts Disease Progression in Half Over 3 Years
Capricor Therapeutics Inc: Deramiocel Was Well Tolerated With No New Safety Signals Identified
FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
First-Ever DMD Cardiomyopathy Treatment Advances: FDA Fast-Tracks Capricor's Groundbreaking Therapy
Capricor Therapeutics Announces FDA Acceptance and Priority Review of Its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
GlobeNewswire· 22 mins ago11mins
Capricor Therapeutics(CAPR.US)
--FDA assigns PDUFA target action date of August 31, 2025--
--If approved, deramiocel would be first therapy to treat Duchenne muscular dystrophy cardiomyopathy--
--At this time, FDA has not identified any potential review issues with the BLA-...
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
No comment yet